ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease (ALPO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01324518
Recruitment Status : Completed
First Posted : March 29, 2011
Last Update Posted : October 21, 2014
Sponsor:
Information provided by (Responsible Party):
Orion Corporation, Orion Pharma

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2012
  Actual Study Completion Date : October 2012

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 27, 2018